Healius, AU0000033359

Simply Wall St lists AUD 0.55 target for Healius stock

Published on 10/15/2026 at 21:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
In fiscal year 2026, revenue rose 2.10 percent to AUD 1.37 billion. Healius stock costs EUR 0.23 on October 15, 2026 at Lang & Schwarz after hours.

Analyst target and company dates

  • Simply Wall St listed an AUD 0.55 target for Healius on October 7, 2026.
  • Fiscal year 2026 revenue rose 2.10 percent to AUD 1.37 billion.
  • Healius stock costs EUR 0.23 at Lang & Schwarz on October 15, 2026 at 8:51 p.m. CEST.
  • The annual general meeting is scheduled for October 22, 2026.
Healius, AU0000033359, Illustration mit AI erstellt.

Healius stock (ISIN AU0000033359) has an AUD 0.55 consensus target, 48.65 percent above the AUD 0.37 ASX price on October 15, 2026 at 3:10 p.m. AEDT, according to Simply Wall St on October 7, 2026. The euro quote stood at EUR 0.23 at Lang & Schwarz on October 15, 2026 at 8:51 p.m. CEST.

Analyst target and meeting date

The AUD 0.55 figure is the average target from 10 analysts listed by Simply Wall St. The target sits 48.65 percent above the ASX price of AUD 0.37, using the same October 15, 2026 quotation. That spread gives investors a concrete measure of how far the consensus view is from the latest Australian listing price.

Healius has its annual general meeting scheduled for October 22, 2026. TipRanks reported that the meeting will begin at 11:00 a.m. Sydney time in a hybrid format.

Fiscal year 2026 revenue

Healius reported underlying revenue of AUD 1.37 billion in fiscal year 2026, up 2.10 percent from the prior year. Group underlying EBITDA increased 8.10 percent to AUD 258.60 million, while underlying EBIT rose to AUD 30.20 million, according to Yahoo Finance on August 19, 2026. Pathology revenue increased 1.80 percent to AUD 1.33 billion in the same period.

The price sits in range

On the ASX, Healius last stood at AUD 0.37 on October 15, 2026 at 3:10 p.m. AEDT. The 52-week range was AUD 0.30 to AUD 1.07, placing the price 23.33 percent above the low and 65.42 percent below the high. Trading volume was 2,953,906 shares against an average of 5,007,194 shares.

Valuation and annual meeting

Healius had a market capitalization of AUD 268.70 million and a trailing P/E ratio of minus 0.65 as of October 15, 2026. The scheduled annual meeting on October 22, 2026 is the next dated corporate event in the investor calendar.

Comparison with peers

Healius (ASX, AUD): P/E minus 0.65, market capitalization AUD 268.70 million.
Sonic Healthcare (ASX, AUD): daily change plus 0.65 percent, P/E 15.03, market capitalization AUD 9.14 billion.
Australian Clinical Labs (ASX, AUD): daily change plus 0.35 percent, P/E 23.03, market capitalization AUD 529.70 million.

Euro quote after hours

The Lang & Schwarz euro quote of EUR 0.23 on October 15, 2026 at 8:51 p.m. CEST places the German trading indication below the Australian listing price stated earlier.

The further course of trading is shown by the continuously updated real-time quote of Healius stock.

Healius stock facts

  • Company: Healius Limited
  • ISIN: AU0000033359
  • Ticker: HLS
  • Primary exchange: ASX
  • Price Lang & Schwarz (as of October 15, 2026, 8:51 p.m. CEST): EUR 0.23
  • Market capitalization: AUD 268.70 million (as of October 15, 2026)
  • 52-week range: AUD 0.30-AUD 1.07 (as of October 15, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Market context: Market report S&P/ASX 200.

More news and analyses on Healius stock

Disclaimer...
en | AU0000033359 | HEALIUS | boerse | 70332492 | bgmi